Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 19/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30097854 | 1.00 | TLR7 (0.44) | TLR7CYP2D6KCNH2CYP3A4CYP2C8 | |
| SCHEMBL23714450 | 0.92 | TLR7 (0.40) | TLR7CYP2D6KCNH2CYP3A4CYP2C8 | |
| SCHEMBL29971178 | 0.90 | TLR7 (0.42) | TLR7CYP2D6KCNH2CYP3A4 | |
| SCHEMBL29971148 | 0.90 | TLR7 (0.42) | TLR7CYP2D6KCNH2CYP3A4 | |
| SCHEMBL23718889 | 0.90 | TLR7 (0.42) | TLR7CYP2D6KCNH2CYP3A4 | |
| SCHEMBL23703504 | 0.88 | TLR7 (0.45) | TLR7CYP2D6KCNH2CYP3A4CYP2C8 | |
| SCHEMBL30097960 | 0.88 | TLR7 (0.45) | TLR7CYP2D6KCNH2CYP3A4CYP2C8 | |
| SCHEMBL23712200 | 0.85 | TLR7 (0.47) | TLR7CYP2D6KCNH2CYP3A4 | |
| SCHEMBL23704425 | 0.84 | TLR7 (0.43) | TLR7CYP2D6KCNH2CYP3A4 | |
| SCHEMBL23704586 | 0.84 | TLR7 (0.43) | TLR7CYP2D6KCNH2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4097103-A1 | 1H-PYRAZOLO[4,3-D]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS | Bristol-Myers Squibb Company (US) | 2022-12-07 | — | — | EP | disclosed |
| EP-4097104-A1 | 1H-PYRAZOLO[4,3-D]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS | Bristol-Myers Squibb Company (US) | 2022-12-07 | — | — | EP | disclosed |
| WO-2021154662-A1 | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-08-05 | — | — | WO | disclosed |
| WO-2021154663-A1 | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-08-05 | — | — | WO | disclosed |